Recordati reported EUR493.59M in Operating Expenses for its fiscal quarter ending in June of 2026.





Operating Expenses Change Date
Almirall EUR 531.16M 13.76M Jun/2026
GlaxoSmithKline GBP 5.8B 468M Jun/2026
Hikma Pharmaceutical USD 1.34B 702M Dec/2025
Orion EUR 345M 42.1M Jun/2026
Sanofi EUR 9.92B 607M Jun/2026